Biotechnology
A recent study has shed new light on the distribution and dynamics of meroplankton in Ambon Bay, Indonesia. The research, conducted by the National Research and Innovation Agency, aimed to investigate the spatial distribution and dynamics of meroplankton in the bay. The study, which spanned from August to November 2022,
Biotechnology
Noakhali Science and Technology University (NSTU) marked a significant milestone with the inauguration of its Biotech Association, a move aimed at fostering a culture of modern and data-driven research within the institution. The event, which took place on November 3, saw the Vice-Chancellor Professor Dr. Muhammad Ismail attend as the
Biotechnology
Bacteriophage therapy has re-emerged as a precise, adaptable, and sustainable antimicrobial alternative to traditional antibiotics, which are rendered ineffective by the global rise of multidrug-resistant (MDR) bacteria. This review, published in Molecular Biology Reports, presents a comprehensive analysis of phage applications across medical, veterinary, agricultural, and environmental sectors. The research
Biotechnology
Researchers at METiS TechBio have made a breakthrough in the development of a novel oral formulation for treating Pseudobulbar Affect (PBA), a neurological condition characterized by sudden, involuntary, and inappropriate episodes of laughing or crying. MTS-004, the company's internally developed small-molecule candidate, has successfully completed Phase III clinical
Biotechnology
Researchers from the Indian Institute of Technology Delhi have developed innovative smart nanocomposites that harness the power of biomolecules to activate the plant immune system, potentially revolutionizing the approach to environmentally sustainable disease management. These nanocomposites, composed of silica nanoparticles and polyelectrolyte complexes, demonstrate improved biopesticide retention and efficacy against
Biotechnology
Researchers at the Department of Biotechnology in India have made a significant breakthrough in using agro-industrial residues to create green synthesized nanomaterials with potential applications in architectural coatings. The study, published in Preparative Biochemistry & Biotechnology, used a novel approach to convert waste pomegranate peel into silver nanoparticles, which showed
Biotechnology
Actinium Pharmaceuticals, Inc. (ATNM) has announced that Sandesh Seth, Chairman and CEO, will participate in the Stephens Biotechnology Virtual Fireside Chat on November 4, 2025. During the conference, members of the company's management team will be available for one-on-one meetings with investors. This event comes as the company
Biotechnology
A new report from the School of Chemical and Biotechnology has shed light on the molecular mechanisms underlying Chronic Obstructive Pulmonary Disease (COPD), identifying key signaling pathways that play crucial roles in disease development and progression. According to the research, targeting these pathways could pave the way for precision medicine
Biotechnology
New research out of the Federal University of Ceara in Brazil has highlighted the potential of lectins as antiviral agents and diagnostic tools in the fight against coronavirus and other viral pathogens. The study, published in the journal ACS Bio & Med Chem Au, explores the molecular interactions between lectins
Antiviral agents
New study results published in the State Research Center of Virology and Biotechnology "Vector" have highlighted significant progress in the field of lentivirus research, particularly in the development of new antiviral drugs using computer modeling methods. The researchers found that pseudovirus technology, which utilizes recombinant viral particles with
Biotechnology
Kubbco, a creative and social media agency, has announced a new livestream event titled "AI for Life Sciences: From Hype to Real Impact," scheduled for November 12, 2025, at 10:00 AM CET. The 60-minute session targets professionals in pharma, biotech, and medtech, offering practical insights into how
Biotechnology
Ventyx Biosciences (NASDAQ: VTYX) sent shockwaves through the biotech industry this week after its oral NLRP3 inhibitor, VTX3232, failed to deliver weight loss in a Phase 2 study targeting obesity and cardiovascular risk factors. However, the stock surged nearly 90% as investors took notice of the drug's striking
